PROTEOCHIP
DEAD

Serial Number

76272272

Owner

ProteoMed GmbH

Attorney

GARY M. NATH

Filing Date

Jun 15, 2001

Add to watchlist:

No watchlists yet
View on USPTO

PROTEOCHIP Trademark

Serial Number: 76272272

PROTEOCHIP is a trademark filed by ProteoMed GmbH on June 15, 2001. The trademark is classified under Class 1 (Chemicals), Class 5 (Pharmaceuticals), Class 9 (Computers & Electronics), Class 42 (Computer & Scientific). The application is currently no longer active.

Owner Contact Info

ProteoMed GmbH

Auf der Morgenstelle 15
72076 Tubingen , DE

Entity Type: 03

Trademark Details

Filing Date

June 15, 2001

Registration Date

Not Registered

Goods & Services

Scientific computer programs for use in database management and bioinformatics; scientific apparatus, namely apparatus for the affinity binding and quantification of proteins, groups of proteins, groups of proteins, or post-translational modifications of proteins or groups thereof, and instruments, namely instruments for the affinity binding and quantification of proteins, groups of proteins, or post-translational modifications of proteins or groups thereof, for use in genomics research, proteomics research, medical research, biotechnological research and food research; diagnostic apparatus, namely apparatus for the affinity binding and quantification of proteins, groups of proteins, or post-translational modifications of proteins or groups thereof, and instruments, namely instruments for the affinity binding and quantification of proteins, groups of proteins, or post-translational modifications of proteins or groups thereof, for use in genomics research, and instruments for analysis of chemical and biological substances, in particular for the analysis of proteins and protein mixtures; optically based, electronically based, radioactively based, magnetically based, mechanically based, physically based, or biologically based detection systems coupled with analog or digital data measuring and data carriers that are used with applied chemical and biochemical substances, in particular with applied peptides and proteins; and parts for all the aforementioned goods

Pharmaceutical preparations for the treatment of AIDS, myelopathy, Parkinson's disease, Alzheimer's Disease, cardiovascular diseases, stroke, epilepsy, multiple sclerosis, cancer and diabetes; veterinary preparations for use in the treatment of pets or livestock; dietetic substances adapted for medical use, namely, dietary supplements; preparations for destroying vermin; fungicides and herbicides for domestic and agricultural use

Chemicals for use in scientific research, namely for the affinity binding, quantification and/or identification of proteins, groups of proteins, or post-translational modifications of proteins or groups thereof, and chemicals for use in industry, namely for the affinity binding, quantification and/or identification of proteins, groups of proteins, or post-translational modifications of proteins or groups thereof; reagents containing proteins and peptides for scientific or research use

Medical and veterinary services; agricultural research services; medical and scientific diagnostic testing, namely, in diagnosing AIDS, myelopathy, Parkinson's Disease, Alzheimer's Disease, cardiovascular diseases, stroke, epilepsy, multiple sclerosis, cancer and diabetes; scientific, medical and industrial research and product development; laboratory research in the field of protein analysis and protein mixtures

Filing History

ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Jul 22, 2004 ABN2
INQUIRY AS TO SUSPENSION MAILED
Dec 8, 2003 CNSI
ASSIGNED TO EXAMINER
Dec 3, 2003 DOCK
ASSIGNED TO EXAMINER
Oct 15, 2003 DOCK
CASE FILE IN TICRS
Oct 15, 2003 CFIT
LETTER OF SUSPENSION MAILED
Nov 14, 2002 CNSL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 9, 2002 CRFA
PAPER RECEIVED
Jul 9, 2002 MAIL
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jul 1, 2002 CRFA
NON-FINAL ACTION MAILED
May 1, 2002 CNRT
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 19, 2002 CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 19, 2001 CRFA
NON-FINAL ACTION MAILED
Aug 21, 2001 CNRT
ASSIGNED TO EXAMINER
Aug 15, 2001 DOCK